The team of cancer genetics experts that deciphered the genetic blueprints of cancer, have developed two new screening tests that have the promise to detect cancer in an early and curable stage. As the names of the tests indicate PapSEEK and UroSEEK, they seek out and find genetic evidence of cancer by detecting DNA released(...)
precision medicine
The Promise of Precision Medicine
Posted by | precision medicine, ResearchAll cancers are fundamentally disorders of acquired defects in genes. The genes serve as blueprints for all of the components of cells and tissues in the human body. In cancers, faulty blueprints lead to malfunctioning cells that grow uncontrollably, spread throughout the body and overwhelm normal organ functions to threaten life itself. Full realization of(...)
A New Issue of Breast Matters
Posted by | Patient Stories, precision medicine, Prevention/Screening, Research, Survivorship, treatmentThe latest issue of Breast Matters is now out on newsstands, and we have it here for you in our brand new digital design. The new issue includes news on our GAITWAY Tumor board, a group of more than a dozen experts who match treatments to the unique genetic characteristics of patients’ tumors. It also(...)
Immunotherapy for Lung Cancer
Posted by | precision medicine, treatmentIt’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer for certain patients. Learn about the latest advances from our Bloomberg~Kimmel Institute for Cancer Immunotherapy and how we are helping patients with lung cancer live better and longer. Watch the(...)
‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle
Posted by | precision medicine*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed one pharmaceutical company's approach to engineering a cancer patient's own T-cells, the so-called soldiers of the immune system, and injecting them back into patients with astounding success has prompted questions(...)
A Conversation about Cancer
Posted by | precision medicine, Prevention/Screening, Research, UncategorizedOn Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H. Owens Auditorium at the Johns Hopkins Kimmel Cancer Center to honor the philanthropy of Sidney Kimmel for advancing cancer discovery and care. Hundreds more watched via video streaming as Kimmel(...)
Gene Friday Series: The Encyclopedia Analogy
Posted by | precision medicineThis blog is part 3 of 4 of our "Gene" Fridays series on cancer genetics. To help people understand the complexity of cancer and the series of genetic events that lead to its formation, Dr. Bert Vogelstein built upon the encyclopedia analogy. “Each of us has an encyclopedia in our cells, and each page of that(...)
Gene Friday Series – No Two Cancers are the Same
Posted by | precision medicineThis blog is part 2 of 4 of our "Gene" Fridays series on cancer genetics. Pancreas cancer was one of the first cancer genomes Dr. Bert Vogelstein and team deciphered. For this study, the scientists examined 24 pancreas cancers and determined the sequence of all of the genes in these cancers. On average, they found just 50(...)
“Gene” Friday Series: Understanding Cancer Genetics
Posted by | precision medicineThis blog is part 1 of 4 of our "Gene" Fridays series on cancer genetics. There is no one better suited to explain the intricacies of cancer genetics than Dr. Bert Vogelstein. He and his team completed the lion’s share of the work that proved that cancer is a genetic disease caused by an accumulation(...)
Gene Patents Get Supreme Decision
Posted by | precision medicineLast week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns Hopkins experts had to say about the topic: "I am thrilled with the Supreme Court's unanimous decision to overturn gene patents. This was the only choice and will open up(...)
1 2